Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Polycystic Kidney Disease - Overview
Polycystic Kidney Disease - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Polycystic Kidney Disease - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Polycystic Kidney Disease - Companies Involved in Therapeutics Development
Polycystic Kidney Disease - Drug Profiles
Polycystic Kidney Disease - Dormant Projects
Polycystic Kidney Disease - Discontinued Products
Polycystic Kidney Disease - Product Development Milestones
Featured News & Press Releases
Jul 13, 2022: XORTX announces positive topline results from pharmacokinetics bridging clinical trial
Jul 07, 2022: XORTX announces pre-phase 3 meeting request with US Food and Drug Administration (FDA)
Jun 21, 2022: Regulus Therapeutics announces receipt of FDA orphan drug desigtion for RGLS8429 for the treatment of autosomal domint polycystic kidney disease (ADPKD)
Jun 13, 2022: Regulus Therapeutics announces first subject dosed in phase 1 Single-Ascending Dose (SAD) Clinical Trial of RGLS8429 for the treatment of autosomal domint polycystic kidney disease (ADPKD)
May 11, 2022: Regulus Therapeutics announces FDA acceptance of Investigatiol New Drug (IND) application for RGLS8429 for the treatment of Autosomal Domint Polycystic Kidney Disease (ADPKD)
May 05, 2022: XORTX opens an IND for XRx-008 program for Autosomal Domint Polycystic Kidney Disease
May 03, 2022: XORTX initiates dosing of human subjects in the XRX-OXY-101 clinical trial
Apr 25, 2022: Poxel announces its participation in upcoming scientific conference of PXL770
Apr 12, 2022: XORTX receives no objection letter from Health Cada
Apr 07, 2022: XORTX announces grant of US patent
Mar 31, 2022: XORTX files IND with US FDA
Mar 14, 2022: XORTX Therapeutics announces submission of clinical trial application to conduct Bridging Pharmacokinetics Study
Jan 20, 2022: Regulus Therapeutics announces successful completion of pre-IND meeting with FDA for RGLS8429
Dec 21, 2021: XORTX Therapeutics announces filing of provision patent for polycystic kidney disease
Dec 01, 2021: Regulus Therapeutics announces presentation at the first annual Rare & Genetic Kidney Disease Drug Development Summit
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures

List of Figures
Number of Products under Development for Polycystic Kidney Disease, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Number of Products by Top 10 Targets, 2022
Number of Products by Stage and Top 10 Targets, 2022
Number of Products by Top 10 Mechanism of Actions, 2022
Number of Products by Stage and Top 10 Mechanism of Actions, 2022
Number of Products by Routes of Administration, 2022
Number of Products by Stage and Top 10 Routes of Administration, 2022
Number of Products by Molecule Types, 2022
Number of Products by Stage and Molecule Types, 2022

List of Tables

List of Tables
Number of Products under Development for Polycystic Kidney Disease, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Companies, 2022 (Contd..1)
Number of Products under Development by Universities/Institutes, 2022
Products under Development by Companies, 2022
Products under Development by Companies, 2022 (Contd..1)
Products under Development by Companies, 2022 (Contd..2)
Products under Development by Universities/Institutes, 2022
Number of Products by Stage and Target, 2022
Number of Products by Stage and Target, 2022 (Contd..1)
Number of Products by Stage and Mechanism of Action, 2022
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Polycystic Kidney Disease - Pipeline by AceLink Therapeutics Inc, 2022
Polycystic Kidney Disease - Pipeline by Amathus Therapeutics Inc, 2022
Polycystic Kidney Disease - Pipeline by AmMax Bio Inc, 2022
Polycystic Kidney Disease - Pipeline by Angion Biomedica Corp, 2022
Polycystic Kidney Disease - Pipeline by ATLAS Molecular Pharma SL, 2022
Polycystic Kidney Disease - Pipeline by Bristol-Myers Squibb Co, 2022
Polycystic Kidney Disease - Pipeline by Camurus AB, 2022
Polycystic Kidney Disease - Pipeline by Centessa Pharmaceuticals Plc, 2022
Polycystic Kidney Disease - Pipeline by Chimerna Therapeutics Inc, 2022
Polycystic Kidney Disease - Pipeline by Chinook Therapeutics Inc, 2022
Polycystic Kidney Disease - Pipeline by DiscoveryBiomed Inc, 2022
Polycystic Kidney Disease - Pipeline by Eloxx Pharmaceuticals Inc, 2022
Polycystic Kidney Disease - Pipeline by Galapagos NV, 2022
Polycystic Kidney Disease - Pipeline by Generian Pharmaceuticals Inc, 2022
Polycystic Kidney Disease - Pipeline by GLG Pharma SA, 2022
Polycystic Kidney Disease - Pipeline by Goldfinch Bio Inc, 2022
Polycystic Kidney Disease - Pipeline by Healx Ltd, 2022
Polycystic Kidney Disease - Pipeline by IC-MedTech Inc, 2022
Polycystic Kidney Disease - Pipeline by Ipsen SA, 2022
Polycystic Kidney Disease - Pipeline by Johnson & Johnson, 2022
Polycystic Kidney Disease - Pipeline by Kadmon Holdings Inc, 2022
Polycystic Kidney Disease - Pipeline by ManRos Therapeutics, 2022
Polycystic Kidney Disease - Pipeline by Mironid Ltd, 2022
Polycystic Kidney Disease - Pipeline by Mitotherapeutix LLC, 2022
Polycystic Kidney Disease - Pipeline by Otsuka Pharmaceutical Co Ltd, 2022
Polycystic Kidney Disease - Pipeline by Pano Therapeutics Inc, 2022
Polycystic Kidney Disease - Pipeline by Poxel SA, 2022
Polycystic Kidney Disease - Pipeline by Reata Pharmaceuticals Inc, 2022
Polycystic Kidney Disease - Pipeline by Regulus Therapeutics Inc, 2022
Polycystic Kidney Disease - Pipeline by Shanghai Alebund Pharmaceuticals Ltd, 2022
Polycystic Kidney Disease - Pipeline by Surrozen Inc, 2022
Polycystic Kidney Disease - Pipeline by XORTX Therapeutics Inc, 2022
Polycystic Kidney Disease - Dormant Projects, 2022
Polycystic Kidney Disease - Dormant Projects, 2022 (Contd..1)
Polycystic Kidney Disease - Discontinued Products, 2022